NeuroSense Therapeutics Ltd. (NRSNW) has 10 known insider and institutional holders on record. The largest holder is Binder Hagit with 521,806 shares. Other notable holders include Ben-Noon Alon and Tracik Ferenc.
Over the last 12 months, insiders have made 25 transactions in NRSNW stock — 3 buys (valued at RSU Award) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
NRSNW Insider Ownership
Top Holder
Binder Hagit
521,806 shares
Buys (12 mo)
3
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Binder Hagit |
General Manager |
521,806 |
2026-03-30 |
|
| 2 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
360,777 |
2026-03-30 |
|
| 3 |
Tracik Ferenc |
Chief Medical Officer |
189,618 |
2026-03-18 |
|
| 4 |
Eisenberg Or |
Chief Financial Officer |
139,416 |
2026-04-01 |
|
| 5 |
Leuchtenberger Mark |
Director |
75,000 |
2026-03-18 |
|
| 6 |
Mandil-levin Revital |
Director |
52,526 |
2026-03-31 |
|
| 7 |
Claiborne Cary J |
Director |
48,000 |
2026-03-18 |
|
| 8 |
Pellizzari Christine A |
Director |
48,000 |
2026-03-18 |
|
| 9 |
Golan Roy |
Director |
24,000 |
2026-03-18 |
|
| 10 |
Russek-blum Niva |
Chief Technology Officer |
10,000 |
2026-03-30 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-26 |
Eisenberg Or |
Chief Financial Officer |
RSU Award |
200,000 |
- |
- |
| 2026-03-18 |
Eisenberg Or |
Chief Financial Officer |
Unknown |
- |
- |
- |
| 2024-08-15 |
Eisenberg Or |
Chief Financial Officer |
Unknown |
66,666 |
$0.75 |
$50K |
| 2021-07-01 |
Eisenberg Or |
Chief Financial Officer |
Unknown |
21,000 |
$0.03 |
$693.00 |
| 2026-03-18 |
Mandil-levin Revital |
Director |
Unknown |
- |
- |
- |
| 2023-03-10 |
Mandil-levin Revital |
Director |
Unknown |
72,000 |
$1.43 |
$102.96K |
| 2026-03-26 |
Russek-blum Niva |
Chief Technology Officer |
RSU Award |
200,000 |
- |
- |
| 2026-03-18 |
Russek-blum Niva |
Chief Technology Officer |
Unknown |
- |
- |
- |
| 2022-04-25 |
Russek-blum Niva |
Chief Technology Officer |
Unknown |
36,000 |
$2.18 |
$78.48K |
| 2026-03-26 |
Binder Hagit |
General Manager |
RSU Award |
200,000 |
- |
- |
| 2026-03-18 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
- |
- |
- |
| 2024-12-05 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
80,000 |
$1.25 |
$100K |
| 2024-08-15 |
Ben-noon Alon |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
26,666 |
$0.75 |
$20K |
| 2026-03-18 |
Tracik Ferenc |
Chief Medical Officer |
Unknown |
- |
- |
- |
| 2024-08-15 |
Tracik Ferenc |
Chief Medical Officer |
Unknown |
66,667 |
$0.75 |
$50K |
| 2022-03-13 |
Tracik Ferenc |
Chief Medical Officer |
Unknown |
108,000 |
$3.51 |
$379.08K |
| 2026-03-18 |
Binder Hagit |
General Manager |
Unknown |
- |
- |
- |
| 2022-11-17 |
Binder Hagit |
General Manager |
Unknown |
36,000 |
$1.99 |
$71.64K |
| 2026-03-18 |
Golan Roy |
Director |
Unknown |
- |
- |
- |
| 2026-03-18 |
Claiborne Cary J |
Director |
Unknown |
- |
- |
- |
| 2023-03-10 |
Claiborne Cary J |
Director |
Unknown |
72,000 |
$1.43 |
$102.96K |
| 2026-03-18 |
Leuchtenberger Mark |
Director |
Unknown |
- |
- |
- |
| 2022-01-01 |
Leuchtenberger Mark |
Director |
Unknown |
192,000 |
$3.51 |
$673.92K |
| 2026-03-18 |
Pellizzari Christine A |
Director |
Unknown |
- |
- |
- |
| 2023-03-10 |
Pellizzari Christine A |
Director |
Unknown |
72,000 |
$1.43 |
$102.96K |